Clinical trial
Evaluation of Postoperative Organ Injury, Risk Factors, and Short-Term Clinical Outcomes in Patients Admitted to Intensive Care After Noncardiac Surgery
NCT07907887 is registered in ClinicalTrials.gov with Ankara Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Postoperative Organ Injury, Risk Factors, and Short-Term Clinical Outcomes in Patients Admitted to Intensive Care After Noncardiac Surgery
- Lead sponsor
- Ankara Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2024
- Completion date
- September 30, 2026
- Enrollment
- 224 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Noncardiac Surgery ICU Cohort
Patients admitted to intensive care after emergency or elective noncardiac surgery who had preoperative troponin measurements and postoperative kidney function data available in their medical records. This retrospective cohort includes 224 patients. Patients with chronic kidney disease are included. No intervention was assigned as part of the study.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Acute Kidney Injury Within 48 Hours After Surgery
Occurrence of acute kidney injury, defined by an increase in serum creatinine of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times the preoperative baseline within the observed 48-hour period, or initiation of renal replacement therapy. Assessment uses the serum creatinine and renal replacement therapy components of KDIGO criteria. Urine output criteria are not used because reliable retrospective data are unavailable.
Lead sponsor's other trials
Ankara Training and Research Hospital, most recent start first.
+56 more trials
Similar trials
Same condition (Acute Kidney Injury) and phase, most recent start first.
+792 more trials See the condition page